Skip to main content
Toggle navigation
Login
Search
Home
Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Y
Yamashiro, Darrell
Columbia University Irving Medical Center
Paper 05 - SYSTEMATIC CHARACTERIZATION AND TARGETING OF MASTER REGULATOR DEPENDENCIES IN COEXISTING OSTEOSARCOMA SUBPOPULATIONS
Location: Harbor Ballroom
Darrell Yamashiro
Favorite
Yang, George
H. Lee Moffitt Cancer Center and Research Institute
Paper 54 - HABITAT ESCALATED ADAPTIVE THERAPY (HEAT): A PHASE 2 TRIAL UTILIZING RADIOMIC HABITAT-DIRECTED AND GENOMIC-ADJUSTED RADIATION DOSE (GARD) OPTIMIZATION FOR HIGH-GRADE SOFT TISSUE SARCOMA
Location: Harbor Ballroom
George Yang
Favorite
Yang, liuzhan
Washington University in St. Louis School of Medicine
FOCAL ADHESION KINASE (FAK) IS A THERPEUTIC TARGET IN CHROMOSOME 8 GAIN-ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Location: Seaport Ballroom DE
liuzhan Yang
Favorite
Yang, Yi
Peking University People’s Hospital
Paper 20 - APATINIB IN COMBINATION WITH IFOSFAMIDE AND ETOPOSIDE VERSUS IFOSFAMIDE AND ETOPOSIDE ALONE IN THE TREATMENT OF RELAPSED OR REFRACTORY OSTEOSARCOMA: A MULTICENTER RANDOMIZED CONTROLLED TRIAL
Location: Harbor Ballroom
Yi Yang
Favorite
Yeap, Beow
mgh
Paper 55 - PHASE I/II DOSE ESCALATION TRIAL WITH PROTON-BASED RADIATION THERAPY FOR CHORDOMAS OF THE SKULL BASE AND CERVICAL SPINE: LONG-TERM OUTCOMES FROM PROG 85-26
Location: Harbor Ballroom
Beow Yeap
Favorite
Yin, Vivien
Moffitt Cancer Center
Paper 24 - A PHASE IB STUDY TO EVALUATE THE FEASIBILITY OF NIVOLUMAB OR NIVOLUMAB WITH AZACITIDINE IN PATIENTS WITH RECURRENT, RESECTABLE OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Location: Harbor Ballroom
Vivien Yin
Favorite
You, Daoqi
Memorial Sloan Kettering Cancer Center
Paper 05 - SYSTEMATIC CHARACTERIZATION AND TARGETING OF MASTER REGULATOR DEPENDENCIES IN COEXISTING OSTEOSARCOMA SUBPOPULATIONS
Location: Harbor Ballroom
Daoqi You
Favorite
Paper 35 - FEASIBILITY OF A HARMONIZED MULTI-SITE PRECLINICAL DRUG TESTING APPROACH BY THE PEDIATRIC RESEARCH IN ONCOLOGY XENOGRAFTING CONSORTIUM (PROXC)
Location: Harbor Ballroom
Daoqi You
Favorite
Yu, Hua
Beckman Research Institute at City of Hope Cancer Center
DIRECTLY TARGETING CIC-DUX4 FUSION AND MYC ONCOPROTEINS FOR UNDIFFERENTIATED ROUND CELL SARCOMAS
Location: Seaport Ballroom DE
Hua Yu
Favorite
Yuki, Kyoko
The Hospital for Sick Children
Paper 98 - A TRANSCRIPTIONAL ATLAS OF MESENCHYMAL TUMOURS PROVIDES A UNIVERSAL DIAGNOSTIC PLATFORM AND REVEALS THE MOLECULAR LANDSCAPE OF RECOGNIZED ENTITIES
Location: Harbor Ballroom
Kyoko Yuki
Favorite
Yustein, Jason
Emory Winship Cancer Institute
Paper 35 - FEASIBILITY OF A HARMONIZED MULTI-SITE PRECLINICAL DRUG TESTING APPROACH BY THE PEDIATRIC RESEARCH IN ONCOLOGY XENOGRAFTING CONSORTIUM (PROXC)
Location: Harbor Ballroom
Jason Yustein
Favorite
Yu, Stephen
The Hospital for Sick Chidlren
Paper 98 - A TRANSCRIPTIONAL ATLAS OF MESENCHYMAL TUMOURS PROVIDES A UNIVERSAL DIAGNOSTIC PLATFORM AND REVEALS THE MOLECULAR LANDSCAPE OF RECOGNIZED ENTITIES
Location: Harbor Ballroom
Stephen Yu
Favorite
Yu, Yiyang
Peking University People's Hospital
Paper 28 - EN BLOC RESECTION FOR SPINAL TUMORS: A SINGLE CENTER EXPERIENCE OF 113 CONSECUTIVE CASES
Location: Harbor Ballroom
Yiyang Yu
Favorite
